Quantcast

Latest Hematopoietic stem cell Stories

2011-07-20 10:22:00

CLEVELAND, July 20, 2011 /PRNewswire/ -- Arteriocyte®, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies announced today that the Ohio Department of Development's Third Frontier Commission awarded a $1 million grant to the company for its "Development and Commercialization of Hematopoietic Stem Cell Expansion for Clinical Applications" as...

2011-07-15 14:47:32

Researches near goal of using a patient's own cells to make stem cells that can replace lost or diseased tissue Scientists at the Salk Institute for Biological Studies have developed an improved technique for generating large numbers of blood cells from a patient's own cells. The new technique will be immediately useful in further stem cell studies, and when perfected, could be used in stem cell therapies for a wide variety of conditions including cancers and immune ailments. "There are...

2011-07-07 05:45:00

MELBOURNE, Australia, July 7, 2011 /PRNewswire/ -- Key points: Mesoblast's first Phase 3 trial submission cleared by United States Food and Drug Administration (FDA) Rapid clearance (within 30 days) further validation of Mesoblast's clinical, regulatory, and manufacturing capabilities Mesoblast's proprietary adult stem cells expand hematopoietic precursor cells in umbilical cord blood 40-fold, enabling rapid bone marrow reconstitution with lowered risk of life-threatening Graft Versus...

675b44d7df9317fca04c023ae2dca784
2011-06-09 09:11:46

Researchers at the University of California, San Diego School of Medicine have identified a gene and a novel signaling pathway, both critical for making the first hematopoietic stem cells (HSCs) in developing vertebrate embryos. The discovery has implications for developing stem cell-based therapies for diseases like leukemia and congenital blood disorders. HSCs are multipotent stem cells that give rise to all blood cell types, including red blood and immune cells. Existing medical treatments...

2011-06-07 08:30:00

CLEVELAND, June 7, 2011 /PRNewswire-USNewswire/ -- Arteriocyte(TM), a leading clinical stage biotechnology company with offices in Cleveland, Ohio, and Hopkinton, Massachusetts, that develops proprietary stem cell and tissue engineering based therapies, announced today that they have entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Institute of Surgical Research (USAISR) at Fort Sam Houston, Texas. The 3-year CRADA, entitled "The Use of...

2011-05-23 13:32:59

A Canadian research team has developed an automated microfluidic cell culture platform to monitor the growth, survival and responses of hundreds of hematopoietic stem cells (HSCs) at the single cell level. This new tool allows scientists to study multiple temporally varying culture conditions simultaneously and to gain new insights on the growth factor requirements for HSC survival. "The ability to perform massively parallel cultures of single non-adherent mammalian cells will provide new...

2011-03-30 08:00:00

RANCHO CORDOVA, Calif., March 30, 2011 /PRNewswire/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that Nanshan Memorial Medical Institute (Nanshan), a leading regenerative medicine company, will be utilizing its AXP® AutoXpress(TM) (AXP) and BioArchive® Systems used to process and store stem cells from cord blood in its two stem cell banks in China. The...

2011-03-28 13:26:00

BOSTON, March 28, 2011 /PRNewswire/ -- For over 15 years now, parents have had the option to save the blood that is found within their baby's umbilical cord immediately following birth. The blood is rich in hematopoietic stem cells (HSC's). These multipotent stem cells have the ability to give rise to all blood cell types. Parents have the peace of mind of knowing that their child, and perhaps siblings and other family members, could in fact use these cells as part of a curative treatment...

d571f2fb0061c0641345e92faaae758f
2011-03-01 13:10:00

When patients receive a bone marrow transplant, they are getting a new population of hematopoietic stem cells. Fresh stem cells are needed when a patient is low on red blood cells, as in anemia, or white blood cells, which can be caused by cancer or even cancer treatments such as irradiation or chemotherapy. The problem is that a bone marrow transplant might not succeed because the transplanted stem cells don't live long enough or because they proliferate too well, leading to leukemia. To...

2011-02-21 16:40:00

SAN DIEGO, Feb. 21, 2011 /PRNewswire/ -- Fate Therapeutics, Inc. presented encouraging preliminary data from an ongoing Phase 1b clinical trial of FT1050 at the 2011 BMT Tandem Meetings in Honolulu, Hawaii (Abstract Number: 198; entitled, "Ex Vivo Treatment of Hematopoietic Stem Cells with 16,16-dimethyl Prostaglandin E2 (FT1050) Improves Engraftment and Hematopoietic Reconstitution"). "We are excited by the emerging clinical trial data that support the future of ex vivo-based...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related